Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 03, 2022

SELL
$223.92 - $287.77 $160,326 - $206,043
-716 Closed
0 $0
Q3 2021

Nov 04, 2021

BUY
$282.99 - $369.05 $19,243 - $25,095
68 Added 10.49%
716 $203,000
Q2 2021

Aug 09, 2021

BUY
$259.0 - $414.71 $167,832 - $268,732
648 New
648 $224,000
Q2 2020

Aug 10, 2020

SELL
$258.66 - $342.55 $188,563 - $249,718
-729 Closed
0 $0
Q1 2020

May 07, 2020

BUY
$268.85 - $341.04 $195,991 - $248,618
729 New
729 $230,000
Q2 2019

Jul 19, 2019

SELL
$219.29 - $241.72 $207,229 - $228,425
-945 Closed
0 $0
Q1 2019

Apr 24, 2019

BUY
$216.71 - $338.96 $19,503 - $30,506
90 Added 10.53%
945 $223,000
Q4 2018

Jan 23, 2019

BUY
$278.5 - $352.75 $238,117 - $301,601
855 New
855 $257,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.4B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Jgp Global Gestao De Recursos Ltda. Portfolio

Follow Jgp Global Gestao De Recursos Ltda. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jgp Global Gestao De Recursos Ltda., based on Form 13F filings with the SEC.

News

Stay updated on Jgp Global Gestao De Recursos Ltda. with notifications on news.